4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) appears in 149 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 10,494,302 | 5,858,427 | 126.37% | $97,736,328.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 5,049,779 | -603,432 | -10.67% | $47,013,442.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 4,205,438 | -4,400,372 | -51.13% | $39,152,628.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 4,145,303 | 80,427 | 1.98% | $38,592,771.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 3,650,737 | 0 | 0.00% | $33,988,361.00 |
| BVF INC/IL | 31 Mar, 2026 | 2,879,289 | -1,750,000 | -37.80% | $26,806,181.00 |
| State Street Corp | 31 Mar, 2026 | 2,707,875 | 18,995 | 0.71% | $25,210,316.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 2,000,000 | 64,000 | 3.31% | $18,620,000.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 1,605,156 | 370,000 | 29.96% | $14,944,002.00 |
| Federated Hermes, Inc. | 31 Mar, 2026 | 1,432,260 | -177,222 | -11.01% | $13,334,340.00 |
| Trails Edge Capital Partners, LP | 31 Mar, 2026 | 1,302,917 | 1,302,917 | 0.00% | $12,130,157.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,065,345 | 53,320 | 5.27% | $9,921,110.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 974,173 | 141,582 | 17.00% | $9,069,551.00 |
| Evergreen Quality Fund GP, Ltd. | 31 Mar, 2026 | 951,474 | 0 | 0.00% | $8,858,223.00 |
| DEUTSCHE BANK AG\ | 31 Mar, 2026 | 708,044 | 3,837 | 0.54% | $6,591,890.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 578,265 | 65,365 | 12.74% | $5,383,647.00 |
| Nuveen, LLC | 31 Mar, 2026 | 561,805 | 403,036 | 253.85% | $5,230,404.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 522,823 | 227,982 | 77.32% | $4,862,901.00 |
| Parkman Healthcare Partners LLC | 31 Mar, 2026 | 522,577 | 522,577 | 0.00% | $4,865,192.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 475,737 | 0 | 0.00% | $4,429,111.00 |